Home > Income Statement > AUROBINDO PHARMA
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹31,724 Cr₹29,002 Cr₹24,855 Cr₹23,455 Cr₹24,775 Cr

What is the latest Revenue of AUROBINDO PHARMA ?

The latest Revenue ratio of AUROBINDO PHARMA is ₹31,724 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹31,724 Cr
Mar2024₹29,002 Cr
Mar2023₹24,855 Cr
Mar2022₹23,455 Cr
Mar2021₹24,775 Cr

How is Revenue of AUROBINDO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹31,724 Cr
9.39
Mar2024 ₹29,002 Cr
16.68
Mar2023 ₹24,855 Cr
5.97
Mar2022 ₹23,455 Cr
-5.32
Mar2021 ₹24,775 Cr -

Compare Revenue of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹79,889.0 Cr 0.8% 4.2% 22.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹99,086.7 Cr 0.8% -9.1% -13.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.8%

4.2%

22.2%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses